Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Innovation Corps Supporting Boostone Sbir - Project Summary Individuals With Opioid Use Disorder (OUD) Face Both Short-term and Long-term Challenges to Healthy and Productive Decision-making. While Recovery Success Is Deeply Affected by Phasic/psychological Propensity for Re-use, Current Strategies for Cravings Control Suffer From Limited Usability and Restricted Utility. the Proposed Innovation (“boostone”) Comprises a Proprietary Software-delivered Method for Just-in-time Management of Such Risk Events, as a Supplement to Standard Medication Assisted Treatment for Oud. Aims Include Platform Refinement and a Real-world Feasibility Study. We Anticipate This Phase I Sbir Will Provide the Foundation for Deployment of Boostone in Active Treatment Settings and for Broader Extensions of the Underlying Novel Technology Framework.
Committed
$300,648
Paid out
$249.7K
83%
Committed, not yet paid
$50.9K
17%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…